IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM)

Genova 16132

1 studies enrolling now · 2 studies all time

What they study most

Colorectal Neoplasms, Melanoma

Studies at this site

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
• A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling